Dr. John Deeken serves as the President of Inova Schar Cancer and Co-Director for the Inova Schar Head and Neck Cancer Program. He joined Inova in 2013 and has more than 24 years of clinical experience in internal medicine and medical oncology.
His clinical research focuses on the use of immunotherapy treatments in patients with head and neck cancer, while his laboratory research takes a closer look at understanding the growing epidemic of head and neck cancers caused by HPV. This includes understanding tumor mutations and proteomics induced by HPV infection and how those tumors can be better treated with immunotherapy and targeted therapies. He believes that gaining a better understanding of genomic factors may explain who might be at risk for developing HPV-caused head and neck cancer.
Dr. Deeken served on the Head and Neck Cancer Scientific Committee and the Government Relations Committee for the American Society of Clinical Oncology (ASCO). He currently serves on ASCO's Health Policy Committee. He is a former member of the FDA’s Oncology Drug Advisory Committee. Before joining Inova, he was director of the head and neck medical oncology program at the Lombardi Comprehensive Cancer Center at Georgetown University and regional director for medical oncology for MedStar Health. He currently serves as professor of medicine at the University of Virginia.
Dr. Deeken received his Doctor of Medicine from Georgetown University, where he also completed his residency in internal medicine. He completed his fellowship training in medical oncology at the National Cancer Institute.
A native of Wisconsin, Dr. Deeken is married with four children.
Research and Publications
View list of publications from Dr. Deeken’s research
Blog Posts
Fighting a Cancer Epidemic With a Vaccine (August 2022)
Preparing for a Shortage of Cancer Doctors (May 2019)
FDA Approves Cutting-Edge Cancer Drug from Inova Schar Cancer Institute Clinical Trial (December 2018)
The Future of Personalized Health at Inova (August 2015)
Why subspecialized cancer care matters (September 2025)
Patient Reviews
About Patient Comments
The Patient Rating score is an average of all responses to physician related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.